retatrutide clinical trial south korea SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized, S. Korean companies join global

All therapies are customized for your health goals and monitored by licensed providers

Women using oral contraceptives should use a backup method of contraception for 4 weeks after initiating tirzepatide and after each dose increase

And because Wegovy is FDA-approved to reduce the risk for serious heart problems in people with obesity or overweight, this can be a loophole

Straume, O., Sviland, L

Morando L, Cesa R, Rasetti R, Harvey R, Strata P

If your genetic profile suggests higher temperature sensitivity, your provider can personalize your starting dose and escalation schedule to minimize sweating while maintaining efficacy